EDGAR filings

Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.

EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.

Form types Filers
Clear

50 rows on this page.

Filed Form Filer Category 8-K items / description Accession
2023-04-25 15-12G
Sio Gene Therapies Inc.
CIK 1636050
Other 0001636050-23-000028
2023-04-24 EFFECT
Sio Gene Therapies Inc.
CIK 1636050
Registrations and prospectuses 9999999995-23-001018
2023-04-17 POS AM
Sio Gene Therapies Inc.
CIK 1636050
Registrations and prospectuses 0001636050-23-000026
2023-04-17 S-8 POS
Sio Gene Therapies Inc.
CIK 1636050
Registrations and prospectuses 0001636050-23-000024
2023-04-12 25-NSE
Sio Gene Therapies Inc.
CIK 1636050
Other 0001354457-23-000271
2023-04-06 25
Sio Gene Therapies Inc.
CIK 1636050
Other 0001636050-23-000017
2023-04-06 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders 0001636050-23-000016
2023-03-17 DEFA14A
Sio Gene Therapies Inc.
CIK 1636050
Proxies 0001636050-23-000013
2023-03-15 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 0001636050-23-000011
2023-02-21 DEFM14A
Sio Gene Therapies Inc.
CIK 1636050
Proxies 0001140361-23-007830
2023-02-14 DEFA14A
Sio Gene Therapies Inc.
CIK 1636050
Proxies 0001636050-23-000009
2023-02-14 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-23-000008
2023-02-14 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-23-000007
2023-02-13 SC 13G/A
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0000919574-23-000939
2023-02-10 SC 13G
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001104659-23-018477
2023-02-09 PREM14A
Sio Gene Therapies Inc.
CIK 1636050
Proxies 0001140361-23-005279
2022-12-14 DEFA14A
Sio Gene Therapies Inc.
CIK 1636050
Proxies 0001636050-22-000056
2022-12-14 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001636050-22-000054
2022-11-10 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-22-000051
2022-11-10 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-22-000050
2022-09-14 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 0001636050-22-000043
2022-08-11 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-22-000041
2022-08-11 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-22-000040
2022-06-14 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-22-000036
2022-06-14 10-K
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-K 0001636050-22-000035
2022-04-27 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 1.02 Termination of a Material Definitive Agreement; 2.02 Results of Operations and Financial Condition; 2.05 Costs Associated with Exit or Disposal Activities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001636050-22-000031
2022-03-18 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 0001636050-22-000027
2022-02-14 SC 13G/A
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001085146-22-001038
2022-02-11 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-22-000025
2022-02-11 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-22-000024
2022-02-11 SC 13G/A
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0000919574-22-000910
2022-02-10 4
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001636050-22-000021
2022-02-10 4
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001636050-22-000020
2022-02-09 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001636050-22-000015
2022-02-07 3
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001636050-22-000013
2022-01-31 8-K/A
Sio Gene Therapies Inc.
CIK 1636050
Current reports 5.07 Submission of Matters to a Vote of Security Holders 0001636050-22-000011
2022-01-31 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001636050-22-000009
2022-01-25 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 0001636050-22-000002
2021-12-09 4
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001636050-21-000099
2021-12-09 4
Sio Gene Therapies Inc.
CIK 1636050
Ownership 0001636050-21-000098
2021-11-12 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-21-000095
2021-11-12 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-21-000094
2021-11-12 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001636050-21-000091
2021-11-01 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001636050-21-000087
2021-10-21 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 9.01 Financial Statements and Exhibits 0001636050-21-000084
2021-10-21 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 7.01 Regulation FD Disclosure; 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001636050-21-000082
2021-10-06 S-8
Sio Gene Therapies Inc.
CIK 1636050
Registrations and prospectuses 0001636050-21-000079
2021-09-24 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits 0001636050-21-000076
2021-08-12 8-K
Sio Gene Therapies Inc.
CIK 1636050
Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001636050-21-000073
2021-08-12 10-Q
Sio Gene Therapies Inc.
CIK 1636050
Financial reports 10-Q 0001636050-21-000072